Sangamo BioSciences upgraded to Overweight from Underweight at Piper Jaffray Piper Jaffray upgraded Sangamo BioSciences two notches to Overweight from Underweight and raised its price target for shares to $10 from $4 after assuming coverage of the stock. Piper says the company has a broad gene therapy platform with increasing visibility.
News For SGMO From The Last 14 Days
Check below for free stories on SGMO the last two weeks.
On The Fly: Analyst Initiation Summary Today's noteworthy initiations include: Arista Networks (ANET) initiated with a Neutral at Citigroup... Casella Waste (CWST) initiated with a Hold at Stifel... CymaBay Therapeutics (CBAY) initiated with an Outperform at Cowen... Finish Line (FINL) initiated with a Buy at Jefferies... Flamel Technologies (FLML) initiated with an Outperform at Leerink... PTC Therapeutics (PTCT) initiated with an Outperform at Oppenheimer... Paramount Gold & Silver (PZG) initiated with a Buy at Noble Financial... Progressive Waste (BIN) initiated with a Hold at Stifel... Prosensa (RNA) initiated with an Outperform at Oppenheimer... Sangamo (SGMO) initiated with an Overweight at JPMorgan... Sarepta (SRPT) initiated with an Outperform at Oppenheimer... Sucampo (SCMP) initiated with a Buy at Roth Capital.